Elanco Animal Health Inc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Elanco Animal Health Inc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | $1.14B | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $1.24B | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $1.19B | May 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $1.03B | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $1.18B | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | $1.21B | May 7, 2025 |
| Q3 | 2024 | Sep 30, 2023 | $1.07B | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | $1.06B | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $1.26B | May 8, 2024 |
| Q3 | 2023 | Sep 30, 2022 | $1.03B | Nov 7, 2023 |
| Q2 | 2023 | Jun 30, 2022 | $1.18B | Aug 7, 2023 |
| Q1 | 2023 | Mar 31, 2022 | $1.23B | May 9, 2023 |
| Q3 | 2022 | Sep 30, 2021 | $1.13B | Nov 8, 2022 |
| Q2 | 2022 | Jun 30, 2021 | $1.28B | Aug 8, 2022 |
| Q1 | 2022 | Mar 31, 2021 | $1.24B | May 9, 2022 |
| Q3 | 2021 | Sep 30, 2020 | $890.00M | Nov 5, 2021 |
| Q2 | 2021 | Jun 30, 2020 | $586.00M | Aug 9, 2021 |
| Q1 | 2021 | Mar 31, 2020 | $658.00M | May 7, 2021 |
| Q3 | 2020 | Sep 30, 2019 | $771.30M | Nov 6, 2020 |
| Q2 | 2020 | Jun 30, 2019 | $781.60M | Jul 30, 2020 |
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($34.00M) | Nov 5, 2025 |
| Q3 | 2025 | Jun 30, 2025 | $11.00M | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $11.00M | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $67.00M | May 7, 2025 |
| Q3 | 2025 | Mar 31, 2025 | $67.00M | Nov 5, 2025 |
| Q2 | 2025 | Mar 31, 2025 | $67.00M | Aug 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $364.00M | Nov 5, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($50.00M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($50.00M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2024 | $32.00M | Nov 5, 2025 |
| Q1 | 2025 | Mar 31, 2024 | $32.00M | May 7, 2025 |
| Q2 | 2025 | Mar 31, 2024 | $32.00M | Aug 7, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.10B) | Nov 7, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($97.00M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($97.00M) | Aug 8, 2024 |
| Q2 | 2024 | Mar 31, 2023 | $103.00M | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $103.00M | May 8, 2024 |
| Q3 | 2024 | Mar 31, 2023 | $103.00M | Nov 7, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($65.00M) | Nov 7, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($10.00M) | Aug 7, 2023 |